Express Scripts Holding Company (ESRX) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio decreased its holdings in Express Scripts Holding Company (NASDAQ:ESRX) by 2.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 399,872 shares of the company’s stock after selling 10,522 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.07% of Express Scripts worth $25,320,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also made changes to their positions in ESRX. Dodge & Cox lifted its position in Express Scripts by 25.7% during the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after buying an additional 7,388,021 shares during the period. Macquarie Group Ltd. lifted its position in Express Scripts by 8.4% during the second quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after buying an additional 922,406 shares during the period. Northern Trust Corp lifted its position in Express Scripts by 12.2% during the second quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock valued at $706,629,000 after buying an additional 1,206,980 shares during the period. Veritas Asset Management LLP lifted its position in Express Scripts by 5.6% during the third quarter. Veritas Asset Management LLP now owns 8,652,910 shares of the company’s stock valued at $547,902,000 after buying an additional 460,338 shares during the period. Finally, Nordea Investment Management AB lifted its position in Express Scripts by 2.6% during the third quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock valued at $462,551,000 after buying an additional 188,528 shares during the period. 88.44% of the stock is owned by institutional investors.

In other Express Scripts news, CEO Timothy C. Wentworth acquired 8,000 shares of Express Scripts stock in a transaction that occurred on Tuesday, October 31st. The stock was bought at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the acquisition, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by company insiders.

Several equities analysts have commented on ESRX shares. Jefferies Group set a $72.00 price objective on Express Scripts and gave the company a “buy” rating in a research report on Tuesday, August 29th. Robert W. Baird raised Express Scripts from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $72.00 to $81.00 in a research report on Friday. Raymond James Financial reissued a “sell” rating on shares of Express Scripts in a research report on Friday. Mizuho set a $67.00 price objective on Express Scripts and gave the company a “hold” rating in a research report on Tuesday, October 24th. Finally, ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, December 4th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $74.40.

Express Scripts Holding Company (NASDAQ:ESRX) opened at $71.55 on Friday. Express Scripts Holding Company has a twelve month low of $55.80 and a twelve month high of $73.42. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $40,523.99, a price-to-earnings ratio of 10.46, a PEG ratio of 1.06 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting the consensus estimate of $1.90. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The company had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. During the same period last year, the company earned $1.74 EPS. Express Scripts’s revenue for the quarter was down 2.9% on a year-over-year basis. sell-side analysts anticipate that Express Scripts Holding Company will post 7.02 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Express Scripts Holding Company (ESRX) Shares Sold by Public Employees Retirement System of Ohio” was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.thelincolnianonline.com/2017/12/17/express-scripts-holding-company-esrx-shares-sold-by-public-employees-retirement-system-of-ohio.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply